Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2005 2
2006 2
2007 2
2010 1
2012 2
2013 1
2015 2
2016 4
2017 3
2018 2
2019 1
2021 1
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Multi-modal cell-free DNA genomic and fragmentomic patterns enhance cancer survival and recurrence analysis.
Moldovan N, van der Pol Y, van den Ende T, Boers D, Verkuijlen S, Creemers A, Ramaker J, Vu T, Bootsma S, Lenos KJ, Vermeulen L, Fransen MF, Pegtel M, Bahce I, van Laarhoven H, Mouliere F. Moldovan N, et al. Among authors: verkuijlen s. Cell Rep Med. 2024 Jan 16;5(1):101349. doi: 10.1016/j.xcrm.2023.101349. Epub 2023 Dec 20. Cell Rep Med. 2024. PMID: 38128532 Free PMC article.
Blood-circulating EV-miRNAs, serum TARC, and quantitative FDG-PET features in classical Hodgkin lymphoma.
Drees EEE, Driessen J, Zwezerijnen GJC, Verkuijlen SAWM, Eertink JJ, van Eijndhoven MAJ, Groenewegen NJ, Vallés-Martí A, de Jong D, Boellaard R, de Vet HCW, Pegtel DM, Zijlstra JM. Drees EEE, et al. Among authors: verkuijlen sawm. EJHaem. 2022 Apr 28;3(3):908-912. doi: 10.1002/jha2.432. eCollection 2022 Aug. EJHaem. 2022. PMID: 36051072 Free PMC article.
Blood-based Monitoring of Relapsed/Refractory Hodgkin Lymphoma Patients Predict Responses to Anti-PD-1 Treatment.
Drees EEE, Jauw YWS, van Dijk E, Borchmann S, Verkuijlen SAWM, Stathi P, Groenewegen NJ, Hijmering NJ, Berry DRAI, Meershoek EJ, Hoogmoed D, Kwakman A, Molenaar TJ, Pegtel DM, Ylstra B, de Jong D, Zijlstra JM, Roemer MGM. Drees EEE, et al. Among authors: verkuijlen sawm. Hemasphere. 2022 Jul 4;6(7):e749. doi: 10.1097/HS9.0000000000000749. eCollection 2022 Jul. Hemasphere. 2022. PMID: 35813096 Free PMC article. No abstract available.
Epstein-Barr virus-targeted therapy in nasopharyngeal carcinoma.
Stoker SD, Novalić Z, Wildeman MA, Huitema AD, Verkuijlen SA, Juwana H, Greijer AE, Tan IB, Middeldorp JM, de Boer JP. Stoker SD, et al. Among authors: verkuijlen sa. J Cancer Res Clin Oncol. 2015 Oct;141(10):1845-57. doi: 10.1007/s00432-015-1969-3. Epub 2015 Apr 29. J Cancer Res Clin Oncol. 2015. PMID: 25920375 Clinical Trial.
Extracellular vesicle miRNA predict FDG-PET status in patients with classical Hodgkin Lymphoma.
Drees EEE, Roemer MGM, Groenewegen NJ, Perez-Boza J, van Eijndhoven MAJ, Prins LI, Verkuijlen SAWM, Tran XM, Driessen J, Zwezerijnen GJC, Stathi P, Mol K, Karregat JJJP, Kalantidou A, Vallés-Martí A, Molenaar TJ, Aparicio-Puerta E, van Dijk E, Ylstra B, Groothuis-Oudshoorn CGM, Hackenberg M, de Jong D, Zijlstra JM, Pegtel DM. Drees EEE, et al. Among authors: verkuijlen sawm. J Extracell Vesicles. 2021 Jul;10(9):e12121. doi: 10.1002/jev2.12121. Epub 2021 Jul 15. J Extracell Vesicles. 2021. PMID: 34295456 Free PMC article.
EBV-IgA antibody responses in endemic and nonendemic populations with nasopharyngeal carcinoma: tumour marker prognostication study and a cross-sectional study.
Budiningsih I, Verkuijlen SAWM, Dachlan YP, Arfijanto MV, Hadi U, Middeldorp JM. Budiningsih I, et al. Among authors: verkuijlen sawm. Ann Med Surg (Lond). 2023 Jul 19;85(9):4394-4403. doi: 10.1097/MS9.0000000000000963. eCollection 2023 Sep. Ann Med Surg (Lond). 2023. PMID: 37663720 Free PMC article.
Sensing of latent EBV infection through exosomal transfer of 5'pppRNA.
Baglio SR, van Eijndhoven MA, Koppers-Lalic D, Berenguer J, Lougheed SM, Gibbs S, Léveillé N, Rinkel RN, Hopmans ES, Swaminathan S, Verkuijlen SA, Scheffer GL, van Kuppeveld FJ, de Gruijl TD, Bultink IE, Jordanova ES, Hackenberg M, Piersma SR, Knol JC, Voskuyl AE, Wurdinger T, Jiménez CR, Middeldorp JM, Pegtel DM. Baglio SR, et al. Among authors: verkuijlen sa. Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):E587-96. doi: 10.1073/pnas.1518130113. Epub 2016 Jan 14. Proc Natl Acad Sci U S A. 2016. PMID: 26768848 Free PMC article.
Cytolytic virus activation therapy for Epstein-Barr virus-driven tumors.
Wildeman MA, Novalic Z, Verkuijlen SA, Juwana H, Huitema AD, Tan IB, Middeldorp JM, de Boer JP, Greijer AE. Wildeman MA, et al. Among authors: verkuijlen sa. Clin Cancer Res. 2012 Sep 15;18(18):5061-70. doi: 10.1158/1078-0432.CCR-12-0574. Epub 2012 Jul 3. Clin Cancer Res. 2012. PMID: 22761471
26 results